Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation

Brain Res. 2011 Aug 17:1407:47-61. doi: 10.1016/j.brainres.2011.06.046. Epub 2011 Jul 2.

Abstract

Acute administration of the dopamine D(4) receptor (D(4)R) agonist PD168,077 induces a down-regulation of the μ opioid receptor (MOR) in the striosomal compartment of the rat caudate putamen (CPu), suggesting a striosomal D(4)R/MOR receptor interaction in line with their high co-distribution in this brain subregion. The present work was designed to explore if a D(4)R/MOR receptor interaction also occurs in the modulation of the expression pattern of several transcription factors in striatal subregions that play a central role in drug addiction. Thus, c-Fos, FosB/ΔFosB and P-CREB immunoreactive profiles were quantified in the rat CPu after either acute or continuous (6-day) administration of morphine and/or PD168,077. Acute and continuous administration of morphine induced different patterns of expression of these transcription factors, effects that were time-course and region dependent and fully blocked by PD168,077 co-administration. Moreover, this effect of the D(4)R agonist was counteracted by the D(4)R antagonist L745,870. Interestingly, at some time-points, combined treatment with morphine and PD168,077 substantially increased c-Fos, FosB/ΔFosB and P-CREB expression. The results of this study give indications for a general antagonistic D(4)R/MOR receptor interaction at the level of transcription factors. The change in the transcription factor expression by D(4)R/MOR interactions in turn suggests a modulation of neuronal activity in the CPu that could be of relevance for drug addiction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Animals
  • Autoradiography
  • Benzamides / pharmacology
  • Caudate Nucleus / drug effects
  • Caudate Nucleus / metabolism*
  • Cyclic AMP Response Element-Binding Protein / biosynthesis
  • Dopamine Agonists / pharmacology
  • Dopamine Antagonists / pharmacology
  • Genes, fos / drug effects
  • Immunohistochemistry
  • In Situ Hybridization
  • Male
  • Morphine / pharmacology*
  • Piperazines / pharmacology
  • Proto-Oncogene Proteins c-fos / biosynthesis
  • Putamen / drug effects
  • Putamen / metabolism*
  • Pyridines / pharmacology
  • Pyrroles / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D4 / agonists
  • Receptors, Dopamine D4 / antagonists & inhibitors
  • Receptors, Dopamine D4 / drug effects*
  • Transcription Factors / biosynthesis*

Substances

  • 3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine
  • Analgesics, Opioid
  • Benzamides
  • Cyclic AMP Response Element-Binding Protein
  • Dopamine Agonists
  • Dopamine Antagonists
  • N-((4-(2-cyanophenyl)-1-piperazinyl)methyl)-3-methylbenzamide
  • Piperazines
  • Proto-Oncogene Proteins c-fos
  • Pyridines
  • Pyrroles
  • Transcription Factors
  • Receptors, Dopamine D4
  • Morphine